Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
FDA approves Novartis' Afinitor tablets for pancreatic NET treatment

FDA approves Novartis' Afinitor tablets for pancreatic NET treatment

CEL-SCI receives Polish government approval to commence Multikine Phase III clinical trial in head, neck cancer

CEL-SCI receives Polish government approval to commence Multikine Phase III clinical trial in head, neck cancer

Top-line results from Lymphoseek NEO3-09 Phase 3 study in breast cancer, melanoma

Top-line results from Lymphoseek NEO3-09 Phase 3 study in breast cancer, melanoma

Temsirolimus with chemotherapy may serve as promising therapy for mesothelioma

Temsirolimus with chemotherapy may serve as promising therapy for mesothelioma

MarginProbe System meets its primary endpoints: Dune Medical Devices

MarginProbe System meets its primary endpoints: Dune Medical Devices

CEL-SCI receives no objection letter to initiate Phase III clinical trial of Multikine in Canada

CEL-SCI receives no objection letter to initiate Phase III clinical trial of Multikine in Canada

Injecting tissue spacers reduces risk of radiation burns to rectum in prostate cancer patients

Injecting tissue spacers reduces risk of radiation burns to rectum in prostate cancer patients

Researchers discover possible role of SCCA in breast cancer progression

Researchers discover possible role of SCCA in breast cancer progression

CEL-SCI initiates Multikine Phase III trial in head and neck cancer

CEL-SCI initiates Multikine Phase III trial in head and neck cancer

Curis reports first quarter net loss of $6.8 million

Curis reports first quarter net loss of $6.8 million

AVEO reports total revenue of $133.6 million for first quarter 2011

AVEO reports total revenue of $133.6 million for first quarter 2011

FDA grants orphan drug status to Provectus' PV-10 for liver cancer treatment

FDA grants orphan drug status to Provectus' PV-10 for liver cancer treatment

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

Worm protein controls key aspects of secretion of growth factors out of cells

Worm protein controls key aspects of secretion of growth factors out of cells

Jennerex and Green Cross report positive phase 2 JX-594 clinical trial for liver cancer

Jennerex and Green Cross report positive phase 2 JX-594 clinical trial for liver cancer

Dogs develop cancer that is biologically similar to a human tumour

Dogs develop cancer that is biologically similar to a human tumour

Bedford Labs launches cancer drug Topotecan Hydrochloride for Injection

Bedford Labs launches cancer drug Topotecan Hydrochloride for Injection

Penile extenders represent an effective lengthening method for men

Penile extenders represent an effective lengthening method for men

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors

Pfizer to support immatics' IMA901 Phase III trial in advanced renal cell carcinoma

Pfizer to support immatics' IMA901 Phase III trial in advanced renal cell carcinoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.